ASCL2 and colorectal carcinoma: Correlation analysis suggests that ASCL2 and ETV4 might reduce immune infiltration (Figures 3(a), 3(b), and 3(c)), which might explain the mechanism of immune evasion and resistance to immunotherapy in MSS CRC.